| http://www.w3.org/ns/prov#value | - Consistent with WHO recommendations, malaria endemic countries which are experiencing high levels of resistance to currently used antimalarial drugs such as chloroquine and sulfadoxine/pyrimethamine (SP) are changing treatment policies from monotherapies to artemisinin-based combination treatments (ACTs).
|
